Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing ...

A newly published Cochrane systematic review examining amyloid-beta-targeting monoclonal antibodies in Alzheimer's disease ...

In the fields of health and medicine, the Cochrane Database of Systematic Reviews may be the most trusted source of information. So when a massive Cochrane review finds that face-masking likely did ...

‘Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease’ was published in the Cochrane Database of Systematic Reviews at ...

A new systematic review of 17 clinical trials found that drugs targeting amyloid beta proteins are likely to have no ...

The Cochrane library has recently updated its website focusing on its two core databases, the Cochrane Database of Systematic Reviews (CDSR) and the Cochrane Central Register of Controlled Trials ...

Objective To undertake a contemporary review of the impact of exercise based cardiac rehabilitation (ExCR) for patients with atrial fibrillation (AF). Data sources CENTRAL, MEDLINE, Embase, PsycINFO, ...

For adults with mild cognitive impairment (MCI) or mild dementia due to Alzheimer disease, amyloid-beta-targeted monoclonal ...